310
Views
3
CrossRef citations to date
0
Altmetric
Treatment

SYmbicort given as needed in mild asthma (SYGMA study): a retrospective subanalysis of the Russian population

, MD, PhDORCID Icon, , MD, PhD, , MD, PhD & , MD, PhD
Pages 989-997 | Received 08 Nov 2020, Accepted 15 Feb 2021, Published online: 08 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sergey Avdeev, Nikolay Voznesenskiy, Marina Boldina, Galina Ignatova, Natalya Kostina, Amirzhan Kulbaisov, Igor Leshchenko & Maarten J H I Beekman. (2022) SABA Overuse in Russia – Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study. Journal of Asthma and Allergy 15, pages 371-379.
Read now

Articles from other publishers (2)

S. N. Avdeev, N. A. Voznesenskiy, N. V. Boldina, E. I. Van’kova, I. V. Zaykova-Khelimskaya, G. L. Ignatova, N. E. Kostina, I. V. Kostrova, E. Yu. Kochegarova, A. M. Kulbaisov, I. V. Leshchenko, S. V. Skal’skiy & D. A. Tikhanov. (2022) Overuse of short-acting β2 -agonists in the Russian population with asthma: the persisting threat. PULMONOLOGIYA 32:5, pages 661-669.
Crossref
Sergey K. Zyryanov, Ilya N. Dyakov & Zaurbek R. Aisanov. (2022) Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation. Terapevticheskii arkhiv 94:7, pages 850-858.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.